Privia Health Group, Inc. (PRVA): Price and Financial Metrics Recent IPO
GET POWR RATINGS... FREE!
PRVA Stock Price Chart Interactive Chart >
PRVA Price/Volume Stats
|Current price||$43.77||52-week high||$50.77|
|Prev. close||$43.74||52-week low||$27.15|
|Day high||$44.25||Avg. volume||619,154|
|50-day MA||$40.42||Dividend yield||N/A|
|200-day MA||$0.00||Market Cap||4.63B|
Privia Health Group, Inc. (PRVA) Company Bio
Privia Health Group, Inc. operates as a physician practice management and population health technology company in the United States. The company comprises regional medical groups, accountable care organizations, and specialty verticals. It offers technology and population health tools to enhance independent providers' workflows; management service organization that enables providers to reduce administrative work focus on their patients; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; physician-led accountable care organization, which engages patients, reduces inappropriate utilization, and enhances coordination and patient quality metrics to drive value-based care and transform the healthcare delivery system; and network for purchasers and payers. The company was founded in 2007 and is headquartered in Arlington, Virginia. Privia Health Group, Inc. operates as a subsidiary of Brighton Health Group Holdings, LLC.
PRVA Latest News Stream
|Loading, please wait...|
PRVA Latest Social Stream
View Full PRVA Social Stream
Latest PRVA News From Around the Web
Below are the latest news stories about Privia Health Group Inc that investors may wish to consider to help them evaluate PRVA as an investment opportunity.
ARLINGTON, Va., July 22, 2021 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that it plans to release financial results for the second quarter ended June 30, 2021 before market open on Monday, August 9, 2021. The press release is expected to be publicly disseminated by 7:00 am ET / 6:00 am CT and will also be available on the Company’s Investor Relations website at ir.priviahealth.com. Privia Health management will host a conference call beginning at 8:00 am ET / 7:
Health Enterprise Partners ("HEP"), a healthcare private equity firm, is pleased to announce five realizations of existing portfolio companies, and a new investment in Kno2, the tenth platform investment out of HEP III. Following a tradition of backing founder-financed businesses, HEP's investment came as part of the first source of institutional capital raised by each of these six companies. "Less than two years ago, HEP invested in Twistle bringing to us much more than capital. They understand
ARLINGTON, Va., June 30, 2021 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that Jaewon Ryu, MD, JD, has been named to the Company’s Board of Directors, effective immediately. In connection with this election, the size of the Board was increased to nine directors. “Jaewon is a renowned healthcare industry leader and we are thrilled to welcome him to the Privia Health board of directors,” said Shawn Morris, Chief Executive Officer of Privia Health. “We believe his d
ARLINGTON, Va., June 21, 2021 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA), a technology-driven, national physician enablement company that collaborates with medical groups, health plans and health systems, today announced that it is set to join the Russell 2000® Index at the conclusion of the 2021 Russell indexes annual reconstitution, effective after the U.S. market opens on June 28, 2021. Annual Russell indexes reconstitution captures the 4,000 largest U.S. stocks as of May 7,
Privia Health shows improving price performance, earning an upgrade to its IBD Relative Strength Rating
PRVA Price Returns